Drugs / S-488410
last change Sep 2015 re-read 3 minutes ago

S-488410

Developed for
non-small cell lung carcinoma
Investigated by
Fukushima Medical University · Shiga University · Shionogi · Showa University · Tohoku University · Tokyo University
+1 more · University of Chicago

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01592617 May 2012 → Aug 2015 non-small cell lung carcinoma Shiga University Unknown No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2010-09-14 OncoTherapy Science, Inc. 食道癌治療用ワクチン S-488410 第Ⅰ/Ⅱ相臨床試験開始に伴うマイルストーン受領のお知らせ oncotherapy.co.jp ↗

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as S-488410 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01592617 ↗
Route Subcutaneous “patients will be vaccinated subcutaneously once a week with S-488410” NCT01592617 ↗